IMTX Competitors & Alternatives
Compare Immatics NV with similar stocks in the same industry
Biotechnology
IMTX
Main Stock$9.95
Tradestie Score
57
Market Cap
$1.09B
Revenue Growth
-0.6%
Analyst Upside
+89.8%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RCUS
Arcus Biosciences, Inc.
|
$30.33
|
$1.43B | - | 60 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$15.54
|
$1.42B | - | 60 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$21.82
|
$1.35B | - | 57 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$38.97
|
$1.32B | - | 61 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$8.28
|
$1.29B | 114.3 | 58 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$32.70
|
$1.29B | - | 61 | Compare |
|
ARDX
Ardelyx, Inc.
|
$5.27
|
$1.29B | - | 49 | Compare |
|
ZYME
Zymeworks Inc.
|
$26.31
|
$1.28B | - | 53 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$5.70
|
$1.27B | - | 52 | Compare |
|
SION
Sionna Therapeutics, Inc. Common Stock
|
$43.99
|
$1.26B | - | 55 | Compare |
More IMTX Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2836)
232 stocks in this industry